Healthcare Market Research Report By MRFR: August 2021

Monday, August 16, 2021

Hi-Tech Medical Devices Market Size Incredible Possibilities and Growth Analysis and Forecast To 2027

Market Overview:

Integration of advanced technology with medical devices has aided the healthcare sector in upgrading the monitoring, diagnostics and treatment procedures. Hi-tech medical devices employ stronger and accurate data capturing ability through improved hardware and software systems. Market Research Future (MRFR) has published a report stating that the global Hi-Tech Medical Devices Market is marked to expand at a remarkable growth rate in the upcoming years.

Market Drivers and Restraints:

Incorporation of technologically advanced healthcare solutions is aiding in accurate diagnosis, optimized monitoring and deliverance of effective treatments in the healthcare sector. Increasing prevalence of chronic diseases, rise in geriatric population and high demand for technologically advanced medical devices are majorly fueling the growth of the global smart devices market. Rapid development in the field of artificial intelligence technology and incorporation machine learning in medical devices have opened a broad pathway for the expansion of the global hi-tech medical devices market.

With increased research and development activities in the healthcare sector and high penetration of IoT in the healthcare sector, the demand for hi-tech medical devices is increasing majorly in the developed and developing regions. Popularity of smartwatches and fitness trackers among the young population and emphasis of leading a healthy lifestyle by real-time health monitoring are some other factors that are propelling the growth of the global hi-tech medical devices market. However, lack of awareness and low technological penetration in underdeveloped regions are likely to restrain the growth of the global hi-tech medical devices market.

Market Segmentation:

The global hi-tech medical devices market has been segmented on the basis of products and mode of application. Based on products, the market has been segmented into smartphones, tablets, smartwatches, fitness trackers, virtual reality sets and others. Based on mode of application, the market has been segmented into handheld, headband, strap, clip, bracelet, shoe sensors and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/hi-tech-medical-devices-market-6614

Regional Analysis:

Geographically, the global hi-tech medical devices market has been segmented into five major regions such as North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. The North America region is projecting significant growth in the global hi-tech medical devices market owing to the extensive utilization of health management platforms, rapid adoption technologically advanced healthcare services, increasing demand for remote patient monitoring in this region. The hi-tech medical devices market in the Asia Pacific region is forecasted to expand at a noteworthy growth rate owing to the presence of large user base, increasing awareness regarding the hi-tech medical devices, availability of such devices at affordable prices and rapid development of healthcare infrastructure in this region. High demand for technologically advanced medical devices, increasing inclination towards home healthcare, and rise in healthcare expenditure are propelling the growth of the hi-tech medical devices market in the Europe region. Lack of awareness, low penetration of advanced technology and poor healthcare facilities are leading to slow growth of hi-tech medical devices market in the Middle East and Africa region.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/6614

Competitive Analysis:

The players operating in the global hi-tech medical devices market are focusing on the expansion of their businesses on a global scale by increasing the research and development expenditure for the introduction of upgraded medical devices that are equipped with artificial intelligence technology and can function on the basis of machine learning. Strategic mergers and acquisitions are aiding the players in maintaining their dominance in the highly competitive environment of the global hi-tech medical devices market.

The leading players profiled by MRFR that are operating in the global hi-tech medical devices market are Apple Inc., Google Inc., Adidas AG, Nike, Sony Corporation, Sony, Xiaomi, Virtual-Realties Limited, and CAE Healthcare.

Diabetes Drug Market Research Report – Global Forecast to 2023

Hip Tendinitis Market Research Report – Global Forecast till 2023

Surgical Stents Market : Global Trends, Analysis and Forecast 2027

Market Analysis

The global Surgical Stents Market is likely to grow at a 7.9% CAGR between 2017- 2023, as per the Market Research Future’s (MRFR) new report. Surgical stents, simply put, are small tube like medical devices that are placed into arteries or blood vessels for opening blockages in vessels. Primarily, stents are used to treat renal and cardiac diseases. Esophageal stents, urinary stents, prostatic stents, biliary stents, cardiac stents, and others are the different types of surgical segments. It is made of different materials such as a standard polymer, biodegradable polymer, and metal. Some of its key applications include urinary tract disease, cardiac disease, and others.

Numerous factors are adding to the global surgical stents market growth. Such factors, according to the new MRFR report, include rising adoption of a sedentary lifestyle, growing consumption of suboptimal diet, increasing adoption of minimally invasive techniques, and the growing number of minimally invasive surgeries. Additional factors adding market growth include changing lifestyle, increasing geriatric population, rising healthcare expenditure, rapid technological advancements, increasing obese and diabetic population, and increasing cases of cardiovascular diseases.

On the contrary, product recalls owing to safety issues, complications risk of infection related to stent implantation, and higher surgery cost are factors that may limit the global surgical stents market growth over the forecast period.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/1044

Market Segmentation

The MRFR report offers an inclusive segmental analysis of the global surgical stents market report based on application, end users, types, and type of materials.

By types, the global surgical stents market is segmented into esophageal stents, urinary stents, prostatic stents, biliary stents, cardiac stents, and others. Cardiac stents are again segmented into artery stents, bio-engineered stents, drug eluting stents, balloon expanding stents, self-expanding stents, dual therapy stents, and others. Urinary stents are again segmented into closed end stents, open end stents, multi loop stents, and double pigtail stents.

By metal, the global surgical stents market is segmented into standard polymer, biodegradable polymer, and metal. Of these, the metal segment will lead the market over the forecast period for its various benefits, such as biocompatibility and enhanced flexibility.

By applications, the global stents market is segmented into urinary tract disease, cardiac disease, and others.

By end users, the global stents market is segmented into hospitals, clinics, others. Among these, hospitals will have a major share in the market over the forecast period.

Regional Analysis

Based on the region, the surgical stents market report covers the recent trends and growth opportunities across North America, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, North America will spearhead the market over the forecast period. Higher healthcare expenditure, presence of well-developed healthcare sector in the region, and rising prevalence of renal cardiac diseases are adding to the growth of the market in the region.

The surgical stents market in Europe is predicted to hold the second-largest share over the forecast period, followed by the Asia Pacific. Factors adding to the surgical stents market in the region include rapidly developing economies, huge patient population, rising prevalence of cardiovascular disorders, favorable government initiatives, and effective strategies undertaken by the government.

The surgical stents market in the RoW is predicted to have sound growth over the forecast period.

Browse Complete Toc :https://www.marketresearchfuture.com/reports/surgical-stents-market-1044

Key Players

Eminent players profiled in the global surgical stents market report include Elixir Medical Corporation (US), Boston Scientific Corporation (US), STI Laser Industries, Ltd (Israel), B. Braun Melsungen AG (Germany), Laserage Technology Corporation (US), Medtronic (US), Amaranth Medical, Inc (US), amg International GmbH (Germany), ELLA – CS, s.r.o. (Czech Republic), Arterial Remodeling Technologies (US), Meril Life Sciences Pvt. Ltd. (India), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), and Angiocare (Netherlands).

Moebius Syndrome Market Research Report - Global Forecast till 2023

Eye Melanoma Market Research Report- Forecast to 2023

Seropositive Rheumatoid Arthritis Drug Market Research Report- Forecast to 2023

Big Data in Healthcare Market: Growth Opportunities, Current and Projected Market Size, Recent Industry Trends and Developments

Market Synopsis

Market Research Future (MRFR) asserts that the global Big Data in Healthcare Market is expected to acquire a market value of USD 17,278.13 million while thriving at a CAGR of 20.69% during the forecast period 2015 to 2022.

The increasing demand for analytics solutions for the health management of the expanding populace is expected to be a significant factor that can propel the healthcare big data analytics market. The growing adoption of mobile health apps and IoT is likely to emphasize the need to manage an enormous amount of data to procure important information, which can augment the market during the assessment period. Furthermore, the surging demand to curb healthcare costs and on-going advancement in the healthcare sector is expected to drive the healthcare big data analytics market.

On the flip side, lack of privacy of the confidential medical records is expected to hinder the market growth during the forecast period. However, advanced real-time care and reduced medication errors are expected to counter the impeding factor that can grow the healthcare big data analytics market.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/791

Market Segmentation

The segmental analysis of the global big data in healthcare market is done by components and services.

The components-based segments of the global big data in healthcare market are hardware and software types. The hardware segment is further segmented into virtual private network (VPN), routers firewalls, email servers, data storage (storage on-premise/ data centers/storage on-demand/storage on-cloud), and wireless access points. The software segment is further segmented into practice management software, electronic health record (EHR) software, workforce management software, revenue cycle management software, and others.

The service-based segments of the global big data in healthcare market are financial analytics, clinical data analytics, and operational analytics. The clinical data analytics is further segmented into quality care, reporting, precision health, population health management, clinical decision support, and compliance. The financial analytics is segmented into claims processing, management, revenue cycle, and risk assessment. The operational analytics is segmented into supply chain analytics and workforce analytics.

Browse Complete Toc : https://www.marketresearchfuture.com/reports/big-data-healthcare-market-791

Regional Analysis

Based on the region, the global market for the big data in healthcare is segmented into North America, Europe, Asia-Pacific, and the Middle East Africa.

According to the research conducted by MRFR, the global market is anticipated to be dominated by the Americas. The region is expected to procure a considerable portion of the market share owing to the growing expenditure on healthcare. The presence of prominent key players in the region is anticipated to grow the region significantly.

Europe is likely to acquire a second position owing to the growing expenditure on health during the forecast period. The demand to curb the rising healthcare costs is expected to be another salient cause that can augment the regional market during the review period.

APAC is likely to be the fastest-growing market during the forecast period owing to the increasing trails and growing geriatric population. Emerging nations, such as India and China, are likely to play a crucial role by developing the healthcare infrastructure.

MEA is anticipated to be majorly driven by the Middle East countries; such as, Saudi Arabia and the UAE, due to economic stability. The African region is likely to witness sluggish growth due to poor economic conditions and underdeveloped healthcare infrastructure. However, there are various untapped opportunities that can aid in uplifting the regional market.

Key Players

Renowned players of the global big data in healthcare market are Cognizant, Dell, Cerner Corporation, GE Healthcare, Optum, Philips, Mckesson, Siemens, Xerox, and others.

Related Report:

Global Medical Drones Market

Global Cell Counting Market Research Report—Forecast till 2025

Global Meningococcal Vaccines Market Research Report—Forecast till 2025

Wearable Ambulatory Monitoring Devices Market

Infrared Thermometer Research Report—Forecast till 2027

Daptomycin Market Research Report—Forecast till 2027

Friday, August 13, 2021

Biosurgery Market to Record Sturdy Growth by 2027

Market Scope

Market Research Future (MRFR) anticipates the Biosurgery Market to attain a healthy CAGR around 7.0% from 2020 to 2027 (assessment period).

Growth Boosters and Deterrents

Major growth boosters in the biosurgery market include the escalating number of surgeries, especially in emerging countries such as Mexico, India, Brazil, and Japan. Soaring number of sports injuries, rising burden of obesity cases, and the surge in spinal issues worldwide have also raised the demand for biosurgeries. With manufacturers increasingly focusing on taking up exhaustive research and development initiatives to create cutting-edge and high performance biosurgery devices, the global market is deemed to witness strong growth in the following years. Moreover, innovations with respect to healthcare technologies and their rapid adoption by the industry should also underpin the market growth during the given period.

The global market will get further boost from the expanding elderly population, which is prone to a number of diseases related to gynaecology, urology and more. Moreover, the mounting preference for minimally invasive procedures in line with frequent technical innovations can also enhance the market size in the future. Canada and the US are witnessing a considerable increase in chronic disorders as sedentary lifestyles have become common. This scenario, in addition to rising government funds to improve the healthcare infrastructure, should work in favor of the global market in subsequent years.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/6246

Although the demand could be negatively affected by the high prices of biosurgery products, the market could still chart a relentless growth trajectory considering the upgradations in the healthcare infrastructure across developing nations.

Market Segmentation

The market for biosurgery has been studied extensively in the MRFR report, while also outlining a few segments, namely product, source, and application.

The key products discussed in the report include hemostatic agents, bone graft substitutes, surgical sealants and adhesives, soft-tissue attachments, staple-line reinforcement agents and adhesion barriers. The market for bone-graft substitutes is the biggest, mainly due to the surging popularity of these products in spine and foot reconstruction surgeries and fractures. Accelerated cases of sports-related injuries along with lower back disorders also push the segmental growth.

The sources considered in the MRFR report are biological as well as natural products.

Some of the major applications are general surgery, neurological surgery, orthopedic surgery, cardiovascular surgery, gynecology surgery, thoracic surgery, urology surgery and reconstructive surgery. The dramatic growth in the number of sports-related wounds and injuries as well as age-related disorders have intensified the growth of the orthopedic surgery segment.

Access Report @ https://www.marketresearchfuture.com/reports/biosurgery-market-6246

Regional Analysis

The biosurgery industry can be geographically divided into APAC/Asia Pacific, Europe, MEA/Middle East Africa and the Americas.

With the biggest market size, America benefits from the rise in lifestyle disorders, and the surging count of obese individuals. The escalating number of age-related surgeries also bolster the market development rate in the region. in addition to that, exhaustive research development activities by eminent manufacturers for introducing superior quality biosurgery products enhances the market share in the United States. Trauma-related injuries are mounting rapidly in the region, as a result of which the need for biosurgical devices has soared as well. The American Association for the Surgery of Trauma estimates that trauma injuries claim more than 16,000 lives every year in the US.

Europe could emerge as the second highest gainer in the global market, backed primarily by the surge in government funding as well as support given to the healthcare industry. The German market for biosurgery is performing particularly well, due to the rising number of vigorous research and development activities.

Asia Pacific is the fastest developing market and should retain its growth pace on the back of the exploding population with high unmet medical requirements as well as the rapid economic surge. The biosurgery market in the region also profits from the lower costs associated with the surgeries and the countries in the region offering high-quality but cost-effective medical treatment. This factor is attracting patients from other countries from Europe and North America, leading to stunning growth of the medical tourism sector in the region. As a result, the biosurgery market should fare even better during the analysis period.

Leading Companies

Hemostasis, LLC, R. Bard, Johnson Johnson, MAQUET Holding B.V. Co. Kg. (Getinge Group), Cohera Medical Inc., Medtronic, PLC., Baxter International, Inc., Sanofi, Pfizer Inc., Stryker Corporation, Cryolife, Inc., Braun Melsungen AG, Commonwealth Serum Laboratories (CSL), Kuros Biosciences Ltd, Integra Lifesciences Holdings Corporation are the top biosurgery manufacturers in the worldwide market.

Several medical instruments manufacturers are striving to adopt the latest technologies while also focusing on commercialization their products to capitalize on the emerging trends in the biosurgery industry. Prominent vendors are acquiring other companies to consolidate their rankings in the global market.

For instance, in January 2021, Arch Therapeutics Inc., manufacturer of advanced self-assembling biosurgical and wound care devices, has given sales and distribution rights to Buffalo Supply Inc., which will leverage its marketing prowess to facilitate the distribution of Arch Therapeutics’ biosurgery-based devices in the US market.

Intraocular Lens Market Research Report – Global Forecast till 2023

Healthcare Electronic Data Interchange Market Research Report – Global Forecast till 2023

Chlorhexidine Gluconate Cloth Market Research Report – Forecast to 2023

Electrochemical Biosensors Market : Opportunities, Demand and Forecasts, 2019 – 2027

Electrochemical Biosensors Market Research Report – Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.

Electrochemical biosensors-Overview

Increasing diabetic population, rising prevalence of chronic and lifestyle diseases, and increasing demand for point-of-care-testing (POCT) devices are major factors contributing to the growth of the market. Additionally, increasing application of biosensors in various industries also accelerates the growth of the market. However, the market growth is restrained by various factors such as strict regulatory requirements, reimbursement policies issues in healthcare systems.

In addition, POCT testing offers various advantages such as cost reduction for laboratory testing, faster results, and increased patient satisfaction. Hence, increasing demand of point of care testing would drive the growth of biosensors market.

The global electrochemical biosensors market is growing at the CAGR of 9.7%.

Browse Full Report @ https://www.marketresearchfuture.com/reports/electrochemical-biosensors-market-2792

Key players in the electrochemical biosensors:

Key players in the automated devices market are F. Hoffmann-La Roche AG (Germany), Medtronic Plc. (U.S.), Bayer AG (Germany), Abbott (U.S.), I-SENS, Inc. (South Korea), Siemens (U.S.) and others. The main focus of these players is tapping the market in developing regions across the globe. Also product differentiation plays an important role for sustaining the growth of key players in the market.

Key developments:

F. Hoffmann-La Roche AG:

Headquartered in Basel, Switzerland; F. Hoffmann-La Roche AG is a company manufacturing and marketing number of innovative diagnostic tests and medicines, across the globe. The company offers various products in the pharmaceutical, diagnostics and research industry.

June, 2017: F. Hoffmann-La Roche AG acquired mySugr to form a leading platform for digital diabetes management

August, 2015: F. Hoffmann-La Roche AG acquired GeneWEAVE to strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE shareholders $190 million upfront and up to USD 235 million in contingent product related milestones

February 2015 : F. Hoffmann-La Roche AG announced the collaboration with BioMed X for the development of Nanomaterial-Based Biosensors for Near-Patient Testing

September 2014: F. Hoffmann-La Roche AG launched Elecsys anti-Müllerian Hormone (AMH) fertility test for assessment of ovarian reserve for pregnancy

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/2792

Medtronic plc.:

Founded in 1949, Medtronic plc is a global healthcare solutions company committed to improving the lives of people through their medical technologies, services, and solutions.

October, 2016: Medtronic plc received an approval for its suite of cardiac rhythm and heart failure devices and leads to be scanned in both 3 and 1.5 Tesla (T) magnetic resonance imaging (MRI) machines. This FDA approval will help the company to strengthen its position in MRI machines segment.

December, 2015: Medtronic plc and Samsung came together in an alliance to accelerate the development of digital health solutions for the millions of people suffering from chronic pain, movement disorders, incontinence, and other conditions who could benefit from neuromodulation therapy. Due to this Medtronics seeks to deliver real-time data to the patients and the physicians so they effectively find the cure for the tracked symptoms.

Abbott:

Headquartered in Illinois, USA, Abbott focuses on discovery, development, manufacture, and sale of health care products. The company operates through four segments namely, established pharmaceutical products, diagnostic products, nutritional products, and vascular products. Additionally, the company has two non-reportable segments, namely, diabetes care and medical optics. The diabetes care division of the company is located in California, U.S. and provides blood glucose meters, blood glucose test strips, sensors, data management decision software, and accessories.

June, 2017: Alere shareholders approve amended merger with Abbott. This merger will further strengthen the global presence of the company.

October, 2016 : Abbott announced collaborations with Celgene and Agios for diagnostic identification of IDH mutations. The agreement focuses on the development and commercialize the diagnostic tests.

April, 2016: Abbott received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.

Siemens:

Siemens is a leading global healthcare company continuously developing their portfolio from medical imaging and laboratory diagnostics to adding managed services, consulting, and healthcare IT services apart from further technologies for therapeutic and molecular diagnostics.

September, 2016: Siemens launched the combination of the Modularis urological shock wave unit and the flat detector technology of the mobile C-arm Cios Fusion. Since, constantly switching between two or even three different control units would be complicated and could lead to errors, the Modularis’ central control unit is a better option. This will help Siemens to strengthen its position in the market.

North America CBCT Dental Imaging Market Research Report - Forecast to 2023

Discography Market Research Report - Global Forecast till 2023

Primary Osteoarthritis Market Research Report - Global Forecast till 2023

Ophthalmic Equipment Market: Overview by Types, Application, Key Players, Regional Outlook, Market Drivers & Restraints

The global Ophthalmic Equipment Market is segmented on the basis of product, application, and end-user.

On the basis of product, the market is segmented into vision care devices, ophthalmology surgical devices, diagnostic and monitoring devices, and others. Vision care devices a segmented into spectacles and contact lens. Contact lenses are further segmented into soft contact lenses, Rigid Gas Permeable lenses (RGP), and hybrid contact lenses. Ophthalmology surgical devices are segmented into cataract surgical devices, vitreoretinal surgical devices, refractive surgical devices, glaucoma surgical devices, ophthalmic microscopes, ophthalmic accessories, and others. Cataract surgical devices are further segmented into Intraocular Lenses (IOLS), Ophthalmic Viscoelastic Devices (OVDS), phacoemulsification devices, cataract surgical lasers, and others. The vitreoretinal surgical devices segment is further segmented into vitreoretinal packs, vitrectomy machines, photocoagulation lasers, illumination devices, vitrectomy probes, and others. The refractive surgical devices segment is further segmented into femtosecond lasers, excimer lasers, and others. Glaucoma surgical devices are further segmented into Glaucoma Drainage Devices (GDDS), and micro-invasive glaucoma surgical devices. Ophthalmic accessories are further segmented into surgical instruments and kits, ophthalmic forceps, ophthalmic spatulas, ophthalmic tips and handles, ophthalmic scissors, macular lenses, ophthalmic cannulas, and others. Diagnostic and monitoring devices are segmented into optical coherence tomography scanners, fundus cameras, perimeters/visual field analyzers, autorefractors and keratometers, ophthalmic ultrasound imaging systems, tonometers, slit lamps, phoropters, wavefront aberrometers, optical biometry systems, ophthalmoscopes, lensmeters, corneal topography systems, chart projectors, specular microscopes, retinoscopes, and others. Ophthalmic ultrasound imaging systems are further segmented into ophthalmic A-scan ultrasound, ophthalmic b-scan ultrasound, ophthalmic ultrasound biomicroscopes, and ophthalmic pachymeters.

On the basis of application, the market is segmented into glaucoma, amblyopia, cataract, retinal detachment, and others.

On the basis of end-user, the market is segmented into hospitals, ophthalmology clinics, diagnostic centers, research centers, and others.

Access Report @ https://www.marketresearchfuture.com/reports/ophthalmic-equipment-market-5973

Regional Analysis

The Americas dominates the global ophthalmic equipment market owing to the increasing prevalence of ophthalmic diseases and presence of a well-developed healthcare sector within the region. Moreover, the increasing healthcare expenditure and presence of key players within the regional boundaries provide a favorable background for the market growth.

Europe is the second largest in the global ophthalmic equipment market. Factors such as the increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region.

Asia Pacific is estimated to be the fastest growing market for ophthalmic equipment. This can be attributed to the presence of developing economies such as India and China and a huge patient population suffering from ophthalmic diseases. Moreover, the increasing healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region.

On the other hand, the Middle East and Africa has the least share in the global ophthalmic equipment market due to the low per capita healthcare expenditure and stringent government policies, especially within the African region. It is estimated that the Middle East holds a majority of the market within the Middle Eastern and African region.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/5973

Key Players

Some of the key players in this market are Alcon (U.S.), Bausch Lomb (U.S.), Carl Zeiss Meditec (Germany), Johnson Johnson (U.S.), Essilor International S.A. (France), Haag-Streit (Switzerland), Nidek (Korea), Staar Surgical (U.S.), Topcon Corporation (Japan), Ziemer Ophthalmic Systems (Switzerland), Hoya Corporation (Japan), Ridex Corporation (U.S.), and others.

Global Brain Ischemia Market Research Report- Forecast To 2027

Global Polyp Biopsy Market Research Report- Forecast To 2022

North America Caloric test Market Research Report - Forecast To 2022

pediatric healthcare Market for Middle East and Africa Detailed Analysis, Growth Factors, Top Key Companies, Trends and Developments, 2018-2027

Market Overview

The pediatric healthcare Market for Middle East and Africa is slated to reach USD 63.6 billion by 2023 at CAGR of 4.1%.

Market Dynamics

Pediatric healthcare is a branch of medicine that deals with the medical treatment of babies, teenagers, and adolescents, as well as their growth and diseases. Since children have a weaker immune system, they are more susceptible to gastrointestinal, allergic, infectious, and other chronic diseases.

The demand for pediatric healthcare in the Middle East and Africa is rapidly expanding. Pediatric treatment is concerned with the well-being of children, babies, and teenagers. Pediatrics is concerned with the physical, emotional, and social well-being of children. Every year, an increase in the number of deaths due to various diseases, viral infections, and malnutrition contributes to the growth of the pediatric healthcare market in this country. The pediatric healthcare market is expanding due to an increase in diseases affecting infants and children. The growth of pediatric healthcare in the Middle East and Africa area is being driven by an increase in short-term and chronic diseases, as well as the development of healthcare infrastructure and facilities. The development of pediatric healthcare in the Middle East and Africa is being driven by technological advancements and government measures to develop the healthcare sector. Due to the growth of the healthcare system as well as the increasing importance of disease diagnosis and treatment in the Middle East, the market is projected to expand at the fastest pace. Furthermore, the government funding for the advancement of innovative therapies has an effect on the market's growth. In Africa and the Middle East. Furthermore, the pediatric healthcare sector is fueled by increased government funding, as well as increased research activities in technological advancements.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/2778

Segmental Analysis

Middle East and Africa Pediatric healthcare Market has been segmented on the basis of type of diseases which comprise Short term diseases, chronic diseases, and others. Diarrhea and an increase in injury-related cases are more common in children, so chronic illness is projected to account for the largest share of the pediatric healthcare market. Children's lower immunity leads to an increased demand for chronic disease services.

On the basis of Therapeutics which comprise cardiology, allergy and immunology, gastroenterology, infectious disease, and others. Due to numerous changes in childcare patterns, increased emissions and reduced immunity, an increase in the number of hospitals and clinics dedicated to childcare, and an increase in demand for the sector, the allergy and immunology segment generated the most revenue. On the other hand, metabolic disorders such as obesity and diabetes, which are caused by a sedentary lifestyle caused by a lack of proper food and physical activity, as well as an increase in childhood hunger, are fueling the segment's development.

On the basis of treatment it segmented into medication, surgery, and others.

Regional Analysis

In terms of the Middle East and Africa sector, the UAE is thought to be the main market for pediatric healthcare in the Middle East and Africa. Furthermore, the Saudi Arabian market is expanding and is the world's second-largest market for pediatric healthcare. Over the forecast era, the introduction of new products for pediatric patients by key players, an increase in government initiatives to raise public awareness about pediatric therapies and disorders, and changes in healthcare infrastructure are expected to create a new opportunity for the pediatric healthcare industry.

The main market for paediatric healthcare is the United Arab Emirates. Due to an increase in health problems among infants and children in Africa, there is a huge demand for paediatric medical devices. In a number of underdeveloped African countries, there is a lot of room for paediatric medical devices and nutritional products to expand. A number of government organizations are assessing healthcare conditions in Africa, and healthcare companies are providing items such as healthcare camps for women and children.

During the forecasted era, the Egypt market, on the other hand, is expected to rise at a steady rate in the Middle East and Pediatric healthcare. The demand in the rest of the Middle East and Africa is expected to rise slowly but steadily.

Report Details @ https://www.marketresearchfuture.com/reports/pediatric-healthcare-market-2778

Competitive Analysis

There are many major players in the Pediatric Healthcare Market, which is moderately competitive. In terms of market share, the market is currently dominated by a few major players. Some major players are introducing new items, while others are disseminating them. Some of the key players in this market are: Novartis AG (Switzerland), AstraZeneca (UK), Janssen Global Services, LLC (Belgium), Eli Lilly and Company (US), Bristol-Myers Squibb Company (US), AMMT (Dubai), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), VPS Healthcare (UAE).

Global Optogenetics Market Research Report - Forecast to 2027

Global Breast cancer Market Research Report- Forecast To 2027

Global Renal dialysis Market Research Report- Forecast To 2027

Corneal Surgery Market Size, significant challenges, Specifications, Analysis Forecast To 2027

Global Corneal Surgery Market is expected to grow at a CAGR of 5.2% during forecasted period 2017-2023.

Corneal surgery devices are the devices used during the transplantation of cornea. Visual impairment can be caused due to genetic factors, diseases like diabetes and other infectious diseases and much more. According to WHO, 422 million people are suffering from diabetes globally and this number is increasing at the rate of 8.5%. According to American Academy of Ophthalmology, diabetes is responsible for causing visual complication in approximately 4.5 million Americans. An increasing number of surgical procedures and rising prevalence of diabetes and other diseases has promoted growth of the market. Increasing aging population, introduction on advanced devices for treatment and increasing healthcare expenditure has also contributed in the growth of the market. Moreover, continuous developments and high advancement in the corneal surgery devices, increasing incidence of diabetes, and increasing number of corneal surgeries has provided fuel for the growth of the market. Whereas, high cost of treatment and risk of infection due to devices has hampered the growth of the market. The risk of infection is very high since the cornea has no blood vessels and it derives its nutrients from the aqueous humor. Thus, prophylaxis treatment is an important part of the treatment even if there is no infection. Cornea rejection, occurs in about 20% of cases. Graft failure can also occur at any time after the cornea is transplanted, even years or decades later. These complications are the greatest barriers for the global corneal surgery market.

Segmentation: Global corneal surgery devices market is segmented on the basis of devices types, into diagnostic devices, corneal surgery devices, vision care. Diagnostic devices are further segmented into fundus cameras, keratometers, corneal topographer, ophthalmic ultrasound imaging systems and other. On the basis of transplantation type, market is segmented into deep anterior lamellar keratoplasty, penetrating keratoplasty, synthetic corneas and other. Synthetic corneas are further segmented into boston keratoprosthesis, alphacor, osteo-odonto-keratoprosthesis. On the basis of procedures, they are segmented into pre-operative examination, penetrating keratoplasty, lamellar keratoplasty On the basis of end users, they are segmented into ophthalmic clinics, hospitals and other.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/913

Regional Analysis

Geographically, Global corneal surgery devices market is dominated by America. America corneal surgery devices market is driven by the increasing number of corneal transplants and rising prevalence of diseases like diabetes and ophthalmic diseases. According to Eye Bank Association of America, more than 47,000 corneal transplants will be performed in the US alone in 2013. According to WHO, 82% of the people living with visual impairment are aged 50 and above. Many diseases are also responsible for causing ocular problems. According to American Academy of Ophthalmology, diabetes is responsible for causing visual complication in approximately 4.5 million Americans. America is segmented into two major regions; North America and South America. Major share for the market is acquired by North America due to well-developed medical sector, presence of huge aging population and high healthcare spending.

Access Report Details @ https://www.marketresearchfuture.com/reports/corneal-surgery-devices-market-913

The key players for the global corneal surgery devices market are Alcon Laboratories Inc. (Switzerland), KeraMED (Canada), Abbott Medical Optics Inc. (US), Bausch Lomb, Inc. (US), Carl Zeiss Meditec AG (Germany), Haag-Streit AG (Switzerland), Ziemer Ophthalmic Systems AG (Switzerland), Topcon Corporation (Japan), Essilor International S.A. (France), Johnson Johnson Private Limited (US), Nidek Co. Ltd. (Japan), Cooper Vision (US)

Global corneal surgery devices market is a saturated market due to the presence of many major and local players. A number of different devices are available in the market and so key players are trying to focus on acquisition and strategic alliances with local companies to minimize the competition.

Alcon Laboratories Inc. is an American medical company specializing in eye care products and is a subsidiary of Novartis. Company is headquartered in Switzerland. Company manufacturers number of diagnostic devices. WaveLight, VERION, EX-PRESS and CENTURION are some of the major diagnostic machines manufactured by the company.

Global Surgical Stents Market Research Report- Forecast To 2027

Global Protein Trends Technologies Market Research Report - Forecast to 2027

Global Post-Operative Pain Management Market Research Report - Forecast to 2027

Cholic Acid Market Size Industry Insights, Top Trends, Drivers, Growth and Forecast to 2027

Cholic Acid Market-Overview

The uptick in cancer cases related to the gallbladder is estimated to spur the Cholic Acid Market. The market's report is efficiently analyzed as per MRFR, which provides outlooks for the global markets. By 2024, the cholic acid market stands to gain a 7.90% CAGR.

The increased research studies being directed into developing treatment options are estimated to create new opportunities for the cholic acid market companies in the forecast period. The improved accessibility to treatment and medical expertise is estimated to stimulate the cholic acid market.

Segmental Analysis

The segmental overview of the cholic acid market is carried out on the basis of application, end user and region. The end user segment of the cholic acid market consists of hospitals, clinics, drug stores and ambulatory surgical centers. The region segment of the cholic acid market comprises of Europe, Asia Pacific, North America, Europe and other regional markets. The application segment of the cholic acid market comprises of medicine, organic acid, and emulsifier.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/8091

Detailed Regional Analysis

The cholic acid market's regional study comprises of Europe, Asia Pacific, North America, Europe, and other vital regional markets. The European regional cholic acid market is anticipated to control the chief segment of the cholic acid market due to the high manufacture of cholic acid and the incidence of key producers. In the Asia Pacific region, the high number of obese persons is one of the risk influences for gallstones contributing to the market's advance in the region. The Asia-Pacific has the second greatest market share globally, which is forecasted to rise in the forecast period. The Americas cholic acid market is expected to grow at the fastest growth rate, with 8.47% CAGR throughout the forecast period Increase in the prevalence of gall bladder cancer in the region, which reflects the growth in gallstones, is expected to lift the progress of the Americas cholic acid market in the forecast period

Competitive Analysis

The creation of market niches or specialization is predicted to support the companies' progress who are operating in the global market. Additionally, the optimization of trade strategies and policies between different countries is estimated to affect the overall market expansion further. The deployment of virtual resources is estimated to bolster the overall market. The market is estimated to reverberate with the developments being initiated in the market. The contenders in the market are estimated to take on a proactive role in the progress of the global market. The focus on accelerating the returns from the capital devoted to innovation is observed to be amplified. The government bodies are predicted to pitch in constructively to keep the markets going on the path of development. The revamp in market operations and the effect of lockdowns are anticipated to fuel the market's progress in the upcoming period. The balance between demand and supply forces should be stabilized to reap the benefits of the market's progress in the upcoming years.

The prominent companies in the cholic acid market are Retrophin, Inc. (U.S.), Daewoong Bio, Inc. (South Korea), Showa Denko K.K. (Japan), Dipharma Francis SRL (Italy), Fujimoto Chemicals (Japan), Kinsy SL (Spain), Industria Chimica Emiliana SRL (Italy), Suzhou Tianlu Biopharmaceuticals Co. Ltd (China), Istituto Biologico Chemioterapico SpA (Italy), New Zealand Pharmaceuticals Limited (New Zealand), Panjin Hengchanglong Pharmaceutical (China), PharmaZell GmbH (Germany), Alchem International Ltd (U.S.), Erregierre SpA (Italy), and Zhejiang Yongning Pharmaceutical (Zhejiang).

Access Report Details @ https://www.marketresearchfuture.com/reports/cholic-acid-market-8091

Industry Updates:

Oct 2020 Retrophin, a San Diego-based firm, purchases Orphan Technologies for USD 90 million in cash upfront. Orphan Technologies will be qualified for up to USD 427 million in landmark payments as well as structured mid-single-digit royalties created on future net sales of OT-58 in Europe and the U.S., with an additional milestone compensation if a pediatric rare disease check is arranged. Retrophin concentrates on rare diseases. Its promoted products comprise Thiola (tiopronin) to deter cystine stone creation in patients with acute homozygous cystinuria, Cholbam (cholic acid) bile acid synthesis illnesses owing to single enzyme deficiencies and peroxisomal disorders counting Zellweger spectrum disorders, among others.

Sep 2020 Gannex Pharma Co., Ltd., a solely owned concern of Ascletis Pharma Inc. and Galmed Pharmaceuticals Ltd., announced that they have arrived into a research arrangement aiming at grouping therapy of ASC41 (THR-beta agonist) and Aramchol (SCD 1 inhibitor) for the medication of non-alcoholic steatohepatitis (NASH). The monetary particulars of this deal are not disclosed. Aramchol is an innovative synthetic small molecule, a conjugate of cholic acid and arachidic acid, connected by a steady amide group.

Healthcare Security Systems Market Research Report - Global Forecast to 2024

Healthcare OEM Market Research Report - Global Forecast to 2027

Global Denture Adhesive Market Research Report - Forecast to 2021

Healthcare Big Data Analytics Market Covering Competitive Scenario & Market Dynamics throughout 2027

Healthcare Big Data Analytics Market -Overview

The massive data being generated in the healthcare sector is a key driver behind the development of the Healthcare Big Data Analytics Market. Reports created by MRFR detail the developments in the industry that can be expected in the market through the forecast period. By 2025, the healthcare big data analytics market is estimated to observe a CAGR of 24.98%.

The enhanced accessibility to investment is estimated o create lucrative options for development in the healthcare big data analytics market through the forecast period. Moreover, the need to have robust systems in place during an emergency as the current pandemic is projected to benefit the healthcare big data analytics market.

Segmental Analysis

The healthcare big data analytics market's segmental appraisal is carried out based on type, product, application, delivery mode, end user, and region. The healthcare big data analytics market's end user segment consists of population health analytics, clinical analytics, financial analytics, operational administrative analytics, and others. The product segment of the healthcare big data analytics market consists of hardware, software, and service. The healthcare big data analytics market's application segment consists of financial analytics, operational administrative analytics, clinical analytics, and population health analytics. The type segment of the healthcare big data analytics market consists of prescriptive analytics, predictive analytics, and descriptive analytics. The mode of delivery segment of the healthcare big data analytics market consists of on-premise and cloud-based model. The healthcare big data analytics market's region segment consists of Europe, Asia Pacific, Americas, and other prominent regional markets.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/726

Detailed Regional Analysis

The healthcare big data analytics market's regional study consists of Europe, Asia Pacific, Americas, and other prominent regional markets. The Americas regional market directed the worldwide market for healthcare big data analytics due to the increasing implementation of big data and analytics solutions by healthcare bodies to make their enterprise more data-driven and growing healthcare spending. The European healthcare big data analytics market is second in the global market. The collective implementation of healthcare insurance, mounting strategic alliances and collaborations in the healthcare sector for data management, and flourishing investments in the healthcare industry in the region are anticipated to drive the European regional market's development. The Asia Pacific is the fastest-growing region in the healthcare big data analytics market through the forecast period due to collective demand for improved healthcare amenities, the incidence of a huge patient group, and an upsurge in government backing for healthcare IT in the region. The countries in the Asia Pacific are accepting advanced technology in the healthcare sector, fueling the healthcare big data analytics market growth in this region.

Competitive Analysis

The rise in acquisitions and mergers is estimated to recreate an encouraging environment for the players, leading to several new product offerings. The government support is estimated to have a positive scope for the development in several key areas of the global market. The use of online channels is estimated to gain more precedence as the market comes to terms with the new business realities. The promotion of international trade is predicted to create a promising overall effect on the market, with many companies choosing this period to test new and untapped markets. The advancement in the global distribution chains is estimated to further enrich the market's progress in the coming period. The market is estimated to move forward with caution due to the experiences gained during the pandemic. The surge in innovation and resynchronization of the operation and distribution cycle is estimated to create a constructive situation for the overall market's future.

The promising companies in the healthcare big data analytics market are Cerner, Medeanalytics, Cotiviti (Verscend Technologies), SAS Institute Inc., Citiustech, Health Catalyst, IBM, Inovalon, Allscripts Healthcare Solutions, McKesson Corporation, Optum, Oracle, and SCIO Health Analytics (An EXL Company).

Browse Complete Toc :https://www.marketresearchfuture.com/reports/healthcare-big-data-analytics-market-726

Industry Updates:

Mar 2021 Cerner has confirmed its USD 375 million cash purchase of Kantar Health, a life sciences data and analytics research company. The contract is a portion of a bigger strategy to cultivate Cerner's data-as-a-service contributions into a billion-dollar revenue concern over the next few years. With Kantar, Cerner will radically expand its competence in clinical research support, branding guidance, commercial planning, and marketing insights to serve life science clienteles. The Kantar purchase is one of several connected initiatives in Cerner's budding data-as-a-service line of business.

Mar 2021 Clarify Health, an enterprise analytics company, has secured USD 115 million in series C funding to increase its self-service healthcare analytics cloud and business software. Clarify Health unites longitudinal information for more than 300 million "exclusive patient lives" from government and commercial entitlements, electronic health records (EHRs) and prescriptions. This data can assist healthcare professionals in managing population health and commercialize biotechnology and pharmaceutical products.

Wearable Ambulatory Monitoring Devices Market

Infrared Thermometer Research Report—Forecast till 2027

Daptomycin Market Research Report—Forecast till 2027

Thursday, August 12, 2021

Glucose Tolerance Test Market Expected To Reach At A Highest Growth During Forecast Period

Market Analysis

The global Glucose Tolerance Test Market is predicted to touch USD 46,815.0 million at a 10.4% CAGR between 2014- 2023, as per the recent analysis by Market Research Future (MRFR). A glucose tolerance test, simply put, is a test that helps to measure how well the cells in a body can engross sugar or glucose after the patient consumes a certain amount of sugar.

Various factors are propelling the global glucose tolerance test market growth. As per the latest MRFR report, such factors include changing lifestyle, urbanization, rising prevalence of diabetes across the world, increasing healthcare awareness, rising lifestyle associated diseases, increasing obese population, and growing aging population.

On the contrary, limited reimbursement, high diagnosis and treatment cost, and the availability of affordable alternative technologies are factors that may limit the global glucose tolerance test market growth over the forecast period. Besides, the grave impact of the ongoing COVID-19 outbreak is also impacting the market growth.
Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/4921

Market Segmentation

The MRFR report offers an inclusive segmental analysis of the global glucose tolerance test market report based on product, indication, and end user.

By product, the global glucose tolerance market is segmented into smart sensors, blood glucose testing kit, and others. The blood glucose testing kit is further segmented into test strips, meters, lancet, and others. Of these, the blood glucose testing kit segment will lead the market over the forecast period. Burgeoning demand for home care for diabetes, rising cases of diabetes, and easy accessibility and use are adding to the segment growth. It is predicted to touch USD 36,164.0 million by 2023.

By indication, the global glucose tolerance test market is segmented into reactive hypoglycaemia, insulin resistance, gestational diabetes, and diabetes. Of these, the diabetes segment will dominate the market over the forecast period. The rising cases of diabetes are adding to the growth of the segment.

By end users, the global glucose tolerance test market is segmented into home, hospitals, and diagnostic clinics. Of these, the diagnostics clinics will have a major share in the market over the forecast period.

Regional Analysis

Based on the region, the global glucose tolerance test market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific, the Middle East and Africa. Of these, the Americas will lead the market over the forecast period. High healthcare expenditure, well-developed technology, and the rising cases of diabetes mellitus (DM) are adding to the global glucose tolerance test market growth in the region.

The global glucose tolerance test market in Europe is predicted to hold the second-largest share over the forecast period. The presence of a growing geriatric population, well-developed healthcare infrastructure, and increasing support from the government for RD are adding to the global glucose tolerance test market growth in the region.

The global glucose tolerance test market in the APAC region is predicted to grow at a fast pace over the forecast period. The presence of ample opportunities for the market development, coupled with the rapidly changing healthcare sector, is adding to the glucose tolerance test market growth in the region.

The global glucose tolerance test market in the MEA is predicted to have the smallest share over the forecast period for the slow poor developing countries, particularly in the African region.
Browse Complete Toc :https://www.marketresearchfuture.com/reports/glucose-tolerance-test-market-4921

Key Players

Leading players profiled in the global glucose tolerance test report include Medtronic PLC, Sanofi, LifeScan, Inc., F. Hoffman-La Roche Ltd, Abbott Laboratories, Dexcom, Inc., and Panasonic. Industry players have incorporated several strategies to create a niche in the market and also cater to the consumers growing needs. These strategies comprise partnerships, collaborations, joint ventures, mergers and acquisitions, new product development and launches, extensive RD activities, contracts, geographic expansions, strategic alliances, and more.

Related Report:

Global Thyroid Test Market

Global Thalassemia Treatment Market Research Report—Forecast till 2025

Global Medical Drones Market

Global Cell Counting Market Research Report—Forecast till 2025

Medical Drones Market : Size, Share, Trends, Latest Innovations, Drivers and Industry Key Events 2018 – 2027

Medical Drones Market-Overview

The need for medical drone facilities has increased considerably due to the situation caused by the COVID induce lockdowns globally. The Medical Drones Market's report is efficiently analyzed as per MRFR, which provides outlooks for the global markets. The market is estimated to display an earning of USD 398 Million by 2025 with the backing of a CAGR of 24.4%.

The surge in creating proper healthcare services for remote areas is estimated to further develop the medical drones market in the forecast period. Moreover, growing approval for innovative technology is estimated to promote the medical drone market's augmentation in the impending period.

Segmental Analysis

The segmental analysis of the medical drones market is carried out on the basis of application, end-user, and region. The medical drone market's application segment consists of blood transfer, vaccine transfer, and pharmaceutical/drug transfer. The end-user segment of the medical drones market consists of blood banks and emergency medical services. The region segment of the medical drones market consists of the Asia Pacific, the Americas, Europe, and other important regions.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/8596

Regional Overview

The medical drone market's regional assessment consists of the Asia Pacific, Americas, Europe, and other important regions. The Americas region held the largest regional medical drones market and is predicted to influence the largest market share throughout the forecast period due to the persistent R&D activity by public and private bodies in the US, rising understanding, and strategic associations among key companies. Furthermore, the governments in the Americas region are also encouraging the use of medical drones. The European medical drones market is anticipated to be the second biggest market in 2025. The medical drones market progress in this region can be accredited to government backing and backing to the healthcare sector, connected with growing research and expansion. The Asia Pacific medical drones market is the fastest rising region for the medical drones market due to the flourishing healthcare infrastructure, intensifying investments in healthcare, and developments by market companies in the region. Also, nations such as India and China are anticipated to be the fastest developing in the region due to governments' emphasis on the approval of new technologies and quicker implementation of best treatment choices from established countries.

Competitive Analysis

The forging of novel international trade relations is estimated to bolster the market's capabilities in the upcoming period. The market is estimated to derive momentum from improvement in operating systems within the market. As the market players understand the advantages of a lean operation framework, the market is estimated to transform considerably. The role of the government bodies in almost every country is estimated to be valuable to restore normalcy and create a growth outlook. The earmarked budget for innovation is set to rise with companies realizing the impact of having a progressive product assortment. The development of novel production processes is likely to enhance market strength further. The stabilization of demand and supply forces is estimated to open up opportunities for expansion in the forecast period. The fast-paced adoption of online services and selling platforms is estimated to reinforce market progress in the upcoming years. The consolidation of market competition is predicted to usher in a new development phase in the impending period.

The illustrious companies in the medical drone market are DHL (Germany), Embention (Spain), Matternet (US), Zipline (US), EHang (China), Vayu (US), DJI (China), TUDelft (The Netherlands), and Flirtey (US).

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/medical-drones-market-8596

Industry Updates:

May 2021 Zipline has extended its service in Nigeria, associating with Cross River State to deliver medicines, vaccines, and blood products to more than 1,000 sites statewide. This collaboration is the second for Zipline in Nigeria, ensuing a February arrangement with Kaduna state. In Nigeria, the Cross River State affiliation with Zipline will provide drone delivery of medical provisions to the region.

June 2021 Dunzo Digital, a Google-backed delivery and e-commerce company, directing a Med-Air group and industry specialists to run experimental BVLOS (Below Visual Line of Sight) drone delivery airlifts for the 'Medicine from the Sky Project.' The goal is to help recover access to healthcare throughout the COVID-19 pandemic. The project intends to help different regions in the state of Telangana for medical provisions. The program introduced by the Government of Telangana in India and the World Economic Forum intends to make a large-scale impact and help control the reach of COVID-19 in the state.

Cardiopulmonary Disease Diagnostics and Treatment Market Research Report – Forecast to 2023

Sterilization Equipment Market Research Report – Forecast to 2023

Duodenal Cancer Market Research Report – Forecast to 2023